Worldwide Clinical Trials provides comprehensive capabilities in executing global oncology clinical trials for biotech companies. We operate with more than 4,000 staff across North America, Europe, and Asia-Pacific, supporting trials from First-in-Human (FIH) through registrational Phase III studies. Our fact sheet outlines our strategic approach to global trial execution, covering critical operational elements such as smart trial designs, global logistics, regulatory compliance, risk-based monitoring, data-driven decision-making, and vendor oversight. With an average of 9+ years of oncology experience across key roles, Worldwide has deep therapeutic expertise in both solid tumor and hematologic indications.
Read our full fact sheet to learn about how we take a flexible, sponsor-focused approach that enables rapid adaptation to protocol amendments and breakthrough designation pathways.
